Zacks Investment Management Raises Position in The Procter & Gamble Company (NYSE:PG)

Zacks Investment Management grew its position in The Procter & Gamble Company (NYSE:PGFree Report) by 11.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,340,451 shares of the company’s stock after acquiring an additional 133,719 shares during the period. Procter & Gamble accounts for 2.0% of Zacks Investment Management’s portfolio, making the stock its 5th largest holding. Zacks Investment Management owned about 0.06% of Procter & Gamble worth $232,166,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of PG. International Assets Investment Management LLC raised its position in Procter & Gamble by 19,030.8% in the 3rd quarter. International Assets Investment Management LLC now owns 3,693,593 shares of the company’s stock worth $639,730,000 after purchasing an additional 3,674,286 shares during the last quarter. Wulff Hansen & CO. increased its stake in shares of Procter & Gamble by 16,292.0% in the 2nd quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock valued at $606,230,000 after buying an additional 3,653,477 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of Procter & Gamble during the third quarter worth $301,950,000. AMF Tjanstepension AB raised its holdings in Procter & Gamble by 416.1% during the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after purchasing an additional 1,466,115 shares during the last quarter. Finally, Icon Wealth Advisors LLC lifted its position in Procter & Gamble by 4,621.9% during the 3rd quarter. Icon Wealth Advisors LLC now owns 1,285,923 shares of the company’s stock valued at $222,722,000 after purchasing an additional 1,258,690 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Down 1.2 %

PG stock opened at $173.83 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The stock has a market capitalization of $409.38 billion, a P/E ratio of 29.97, a P/E/G ratio of 3.77 and a beta of 0.44. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $180.43. The business has a 50-day moving average of $170.75 and a 200-day moving average of $169.34.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm’s revenue was down .6% compared to the same quarter last year. During the same period last year, the company earned $1.83 earnings per share. On average, sell-side analysts anticipate that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.32%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Analyst Upgrades and Downgrades

PG has been the subject of a number of recent research reports. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a research note on Monday, September 30th. Evercore ISI increased their price target on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 price objective on shares of Procter & Gamble in a research note on Monday, October 21st. Morgan Stanley increased their target price on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Finally, Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $180.45.

Read Our Latest Stock Report on PG

Insiders Place Their Bets

In related news, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the sale, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Susan Street Whaley sold 634 shares of the business’s stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the transaction, the insider now directly owns 19,341 shares in the company, valued at approximately $3,319,882.65. This trade represents a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 83,080 shares of company stock valued at $14,629,038 in the last 90 days. 0.18% of the stock is currently owned by insiders.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.